CoreAge Rx GLP-1 Support
A three-strain probiotic with prebiotic fibre, targeting the gut rather than appetite directly
Advertising disclosure: We earn commissions from some of the products we link to. It never changes our scores or what we publish. Read the full disclosure
I read what these companies publish about themselves — every ingredient, dose, price and cancellation term — and mark every gap where they publish nothing. Researched from public sources rather than hands-on tested, and we earn no commission on any of it.
No sponsored placements. No paid reviews. Here is exactly how we make money.
Featured placement
A three-strain probiotic with prebiotic fibre, targeting the gut rather than appetite directly
Featured placement
This position was chosen by us, not produced by our evidence ordering, and it did not earn the spot by out-performing anything. No money is involved — we are not paid for it and earn no commission on it. Everything below is ordered on published evidence as normal. Full terms
Read from the source
Every figure comes off the company's own published pages, and each entry carries the date we read it.
Nothing here pays us
We earn no commission on any supplement or provider on this site, including the featured placement.
Gaps stay visible
Where a company publishes nothing, the entry says so rather than filling the gap in for them.
The featured placement, then the products whose manufacturers publish the most about them. Not a verdict on what works — we do not test these.
A three-strain probiotic with prebiotic fibre, targeting the gut rather than appetite directly
1,525mg of fibre in two capsules at 63¢ a day — a published total, and well below research doses
5g of plain creatine monohydrate, nothing else — the correct dose of the best-evidenced ingredient on this site
What works depends enormously on what you are actually trying to solve.
Capsules, powders and 'fat burners' sold without a prescription — where the gap between marketing and evidence is widest.
138 researched
GLP-1 medications and the services that prescribe them, checked against what each company publishes about pricing, medication type and terms.
461 researched
Semaglutide and tirzepatide are the only things in this market with large randomised trials behind them — which is exactly why the companies selling them deserve scrutiny. We researched what 461 online providers actually publish about pricing, medication type and terms, and marked every gap where they publish nothing.
Researched from published sources, not hands-on tested. No scores, and we earn no commission from any of them.
Their actives sit behind a proprietary blend, so you cannot tell whether any ingredient reaches the amount its research used. That is the manufacturer's choice, and it is worth knowing before you buy.
6-7g of prebiotic fibre per serving, behind a proprietary blend
The best-known Akkermansia product, from the company that commercialised the strain
Every entry carries the date we read the manufacturer's pages. These are the newest.
Four ordinary vitamins in a daily packet, sold for people already on a GLP-1 rather than as a substitute for one
States plainly on its own product page that it is not a GLP-1 agonist and contains no GLP-1
Makes drug-scale weight loss claims — 12% body weight in ten weeks — without naming the trial behind them
Free guides with no product placement in them.
The specific claims, structures and design patterns that reliably predict a product is not worth your money — and why each one works on people.
9 min read
PrescriptionWhat this class of drugs actually does in the body, what the trial evidence supports, what the side effects are, and the question about stopping that most services avoid.
11 min read
SupplementsServing sizes, proprietary blends, third-party certification marks, and the regulatory gap that explains why so much of this shelf is ineffective.
8 min read